Director/PDMR Shareholding

RNS Number : 0838O

Venn Life Sciences Holdings PLC

02 November 2016

 

Venn Life Sciences Holdings Plc
("Venn Life Sciences" or the "Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Allan Wood
2	Reason for the notification
a)	Position/status	Chairman (PDMR)
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) b)	Name LEI code	Venn Life Science Holdings PLC Pending
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of nominal value of 0.1 pence each
	Identification code	ISIN GB00B9275X97
b)	Nature of the transaction	Acquisition of ordinary shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			21.50p per share	65,000
			21.73p per share	165,000
d)	Aggregated information
	- Aggregated volume	230,000
	- Price	21.67 pence per share
e)	Date of the transaction	31 October 2016
f)	Place of the transaction	London Stock Exchange AIM market

Venn Life Sciences Holdings Plc		www.vennlifesciences.com
Tony Richardson, Chief Executive Officer		Tel: [phone]
Davy (Nominated Adviser, ESM Adviser and Joint Broker)
Fergal Meegan / Matthew de Vere White (Corporate Finance)		Tel: [phone]
Paul Burke (Corporate Broking)
Hybridan LLP (Co-Broker)
Claire Louise Noyce		Tel: [phone]
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Paul McManus		Mob: [phone]
Lianne Cawthorne		Mob: [phone]

About Venn Life Sciences: Venn Life Sciences is a Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn also has an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.

 

END

 

 

DSHLIFIDLLLFIIR